{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:44:05Z","timestamp":1792147445020,"version":"4.4.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12012-026-10206-8","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:06:02Z","timestamp":1791187562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of Benzodiazepines on Heart Failure Outcomes and Adverse Events: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"26","author":[{"given":"Yi-Sin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galuh Nawang","family":"Prawesti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chun","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Ching","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiang-Yin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"10206_CR1","doi-asserted-by":"crossref","unstructured":"Gao, J., Cao, H. S., Han, L., Luo, X. Q., Xu, L. Y., Zhou, Y., & Ren, J. Y. (2025). Association between insomnia symptoms and risk of heart failure: A meta-analysis of prospective cohort studies. Journal of Cardiology.","DOI":"10.21203\/rs.3.rs-5895499\/v1"},{"key":"10206_CR2","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.125.322880","author":"J Fernandez-Mendoza","year":"2026","unstructured":"Fernandez-Mendoza, J. (2026). Mechanisms linking insomnia and cardiometabolic disease risk. Arteriosclerosis, Thrombosis, and Vascular Biology. https:\/\/doi.org\/10.1161\/atvbaha.125.322880","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"21","key":"10206_CR3","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/eurheartj\/eht019","volume":"35","author":"LE Laugsand","year":"2014","unstructured":"Laugsand, L. E., et al. (2014). Insomnia and the risk of incident heart failure: A population study. European Heart Journal, 35(21), 1382\u20131393.","journal-title":"European Heart Journal"},{"issue":"6","key":"10206_CR4","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/eurjpc\/zwae263","volume":"32","author":"Y Xie","year":"2025","unstructured":"Xie, Y., et al. (2025). Hypnotic use and the risk of cardiovascular diseases in insomnia patients. European Journal of Preventive Cardiology, 32(6), 466\u2013474.","journal-title":"European Journal of Preventive Cardiology"},{"issue":"9","key":"10206_CR5","first-page":"1842","volume":"54","author":"A Gazerani","year":"2025","unstructured":"Gazerani, A., et al. (2025). Sleep quality in heart failure patients: A systematic review of risk factors and assessment tools. Iran J Public Health, 54(9), 1842\u20131856.","journal-title":"Iran J Public Health"},{"issue":"17","key":"10206_CR6","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich, P. A., et al. (2022). 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: A report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines. Journal of the American College of Cardiology, 79(17), e263\u2013e421.","journal-title":"Journal of the American College of Cardiology"},{"issue":"36","key":"10206_CR7","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh, T. A., et al. (2021). 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC) with the special contribution of the heart failure association (HFA) of the ESC. European Heart Journal, 42(36), 3599\u20133726.","journal-title":"European Heart Journal"},{"issue":"5","key":"10206_CR8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.sleep.2004.04.001","volume":"5","author":"CM Morin","year":"2004","unstructured":"Morin, C. M., B\u00e9langer, L., & Bernier, F. (2004). Correlates of benzodiazepine use in individuals with insomnia. Sleep Medicine, 5(5), 457\u2013462.","journal-title":"Sleep Medicine"},{"issue":"1","key":"10206_CR9","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s11886-025-02256-1","volume":"27","author":"ME Atay","year":"2025","unstructured":"Atay, M. E., & \u00c7ift\u00e7i, B. (2025). Insomn\u0131a \u0131n heart fa\u0131lure pat\u0131ents \u0131n a hosp\u0131tal sett\u0131ng: causes, consequences, and intervent\u0131ons. Current Cardiology Reports, 27(1), 108.","journal-title":"Current Cardiology Reports"},{"key":"10206_CR10","doi-asserted-by":"crossref","unstructured":"Jorge-Samitier, P., Fern\u00e1ndez-Rodrigo, M. T., Ju\u00e1rez-Vela, R., Ant\u00f3n-Solanas, I., & Gea-Caballero, V. (2021). Management of hypnotics in patients with insomnia and heart failure during hospitalization: a systematic review. Nursing Reports, 11(2), 373-381.","DOI":"10.3390\/nursrep11020036"},{"key":"10206_CR11","doi-asserted-by":"crossref","unstructured":"Yang, R., Yu, H., Wu, J., Wang, S., Chen, H., Wang, M., & Hu, Y. (2024). Association of benzodiazepine and Z\u2010hypnotic use with cardiovascular disease risk: insights from a prospective study of 10 million people in China. Psychiatry and Clinical Neurosciences, 78(12), 776-782.","DOI":"10.1111\/pcn.13735"},{"issue":"4","key":"10206_CR12","volume":"107","author":"C Mo","year":"2024","unstructured":"Mo, C., et al. (2024). Benzodiazepine use and incident risk of sudden cardiac arrest in patients with cardiovascular diseases. Science Progress, 107(4), Article 368504241295325.","journal-title":"Science Progress"},{"issue":"6","key":"10206_CR13","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/ejhf.1450","volume":"21","author":"C O\u2019Connor","year":"2019","unstructured":"O\u2019Connor, C., et al. (2019). Clinical factors related to morbidity and mortality in high-risk heart failure patients: The GUIDE-IT predictive model and risk score. European Journal Of Heart Failure, 21(6), 770\u2013778.","journal-title":"European Journal Of Heart Failure"},{"key":"10206_CR14","doi-asserted-by":"crossref","unstructured":"Ribeirinho-Soares, P. (2023). Benzodiazepine use and mortality in chronic heart failure. Pol Arch Intern Med, 133(10).","DOI":"10.20452\/pamw.16464"},{"issue":"3","key":"10206_CR15","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4103\/0259-1162.123280","volume":"7","author":"K Anand","year":"2013","unstructured":"Anand, K., & Kumar, M. (2013). Benzodiazepine overdose associated atrioventricular block. Anesthesia Essays and Researches, 7(3), 419\u2013420.","journal-title":"Anesthesia Essays and Researches"},{"key":"10206_CR16","doi-asserted-by":"crossref","unstructured":"Zamani, F. & Doustkhah, E (2022) Chap. 1 - An introduction to benzodiazepines and benzothiazepines, in Benzodiazepine-Based Drug Discovery, F. Zamani and E. Doustkhah, Editors, Elsevier. pp. 1\u20138.","DOI":"10.1016\/B978-0-12-824516-3.00007-0"},{"key":"10206_CR17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/B978-0-323-42973-3.00025-1","volume-title":"Hypertension: A Companion to Braunwald's Heart Disease (Third Edition)","author":"A Hughes","year":"2018","unstructured":"Hughes, A. (2018). 25 - Calcium Channel Blockers. Hypertension: A Companion to Braunwald\u2019s Heart Disease (Third Edition) (pp. 242\u2013253). Elsevier."},{"key":"10206_CR18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/B978-008044992-0.01209-8","volume-title":"Comprehensive Heterocyclic Chemistry III","author":"W Dehaen","year":"2008","unstructured":"Dehaen, W., & Ngo, T. H. (2008). 13.09\u20131,4-Oxazepines and 1,4-Thiazepines. In A. R. Katritzky (Ed.), Comprehensive Heterocyclic Chemistry III (pp. 255\u2013298). Elsevier."},{"issue":"1","key":"10206_CR19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00000542-199901000-00026","volume":"90","author":"M Yamakage","year":"1999","unstructured":"Yamakage, M., et al. (1999). Inhibitory effects of diazepam and midazolam on Ca2\u2009+\u2009and K+ channels in canine tracheal smooth muscle cells. Anesthesiology, 90(1), 197\u2013207.","journal-title":"Anesthesiology"},{"issue":"22","key":"10206_CR20","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1016\/0006-2952(88)90623-5","volume":"37","author":"M Chiesi","year":"1988","unstructured":"Chiesi, M., Schwaller, R., & Eichenberger, K. (1988). Structural dependency of the inhibitory action of benzodiazepines and related compounds on the mitochondrial Na+-Ca2\u2009+\u2009exchanger. Biochemical Pharmacology, 37(22), 4399\u20134403.","journal-title":"Biochemical Pharmacology"},{"key":"10206_CR21","doi-asserted-by":"crossref","unstructured":"Fukuta, H., Goto, T., & Kamiya, T. (2024). Effects of calcium channel blockers in patients with heart failure with preserved and mildly reduced ejection fraction: A systematic review and meta-analysis (Vol. 55, p. 101515). IJC Heart & Vasculature.","DOI":"10.1016\/j.ijcha.2024.101515"},{"issue":"9","key":"10206_CR22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4070\/kcj.2009.39.9.367","volume":"39","author":"JH Lee","year":"2009","unstructured":"Lee, J. H., et al. (2009). Prognosis and natural history of drug-related bradycardia. Korean Circulation Journal, 39(9), 367\u2013371.","journal-title":"Korean Circulation Journal"},{"issue":"5","key":"10206_CR23","first-page":"573","volume":"38","author":"C Chuang","year":"2022","unstructured":"Chuang, C., et al. (2022). Benzodiazepines in patients with heart failure and reduced ejection fraction. Acta Cardiologica Sinica, 38(5), 573\u2013583.","journal-title":"Acta Cardiologica Sinica"},{"issue":"6","key":"10206_CR24","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1159\/000491879","volume":"87","author":"C Diez-Quevedo","year":"2018","unstructured":"Diez-Quevedo, C., et al. (2018). Benzodiazepine use and long-term mortality in real-life chronic heart failure outpatients: A cohort analysis. Psychotherapy and Psychosomatics, 87(6), 372\u2013374.","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"1","key":"10206_CR25","volume":"16","author":"I Ivanov","year":"2024","unstructured":"Ivanov, I., et al. (2024). Benzodiazepine and zolpidem-induced bradycardia: A case report. Cureus, 16(1), Article e52178.","journal-title":"Cureus"},{"issue":"2","key":"10206_CR26","first-page":"216","volume":"30","author":"A Okulevi\u010di\u016bt\u0117","year":"2023","unstructured":"Okulevi\u010di\u016bt\u0117, A., & Sakalauskien\u0117, G. L. (2023). Narrative literature review of potential atrial fibrillation mechanism of action induced by discontinuation of benzodiazepines. Acta Med Litu, 30(2), 216\u2013221.","journal-title":"Acta Med Litu"},{"key":"10206_CR27","volume":"372","author":"MJ Page","year":"2020","unstructured":"Page, M. J., et al. (2020). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, Article n71.","journal-title":"BMJ"},{"key":"10206_CR28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2288-14-45","volume":"14","author":"CK Lo","year":"2014","unstructured":"Lo, C. K., Mertz, D., & Loeb, M. (2014). Newcastle-Ottawa scale: Comparing reviewers\u2019 to authors\u2019 assessments. Bmc Medical Research Methodology, 14, 45.","journal-title":"Bmc Medical Research Methodology"},{"issue":"3","key":"10206_CR29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7(3), 177\u2013188.","journal-title":"Controlled Clinical Trials"},{"issue":"11","key":"10206_CR30","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins, J. P., & Thompson, S. G. (2002). Quantifying heterogeneity in a meta-analysis. Statistics In Medicine, 21(11), 1539\u20131558.","journal-title":"Statistics In Medicine"},{"issue":"6","key":"10206_CR31","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/aje\/kwr144","volume":"174","author":"NH Rod","year":"2011","unstructured":"Rod, N. H., Andersen, I., & Prescott, E. (2011). Psychosocial risk factors and heart failure hospitalization: A prospective cohort study. American Journal of Epidemiology, 174(6), 672\u201380.","journal-title":"American Journal of Epidemiology"},{"issue":"3","key":"10206_CR32","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/jep.13254","volume":"26","author":"CB Yeh","year":"2020","unstructured":"Yeh, C. B., et al. (2020). Association of alprazolam with major cardiovascular events in patients with hypertension. Journal of Evaluation in Clinical Practice, 26(3), 983\u2013991.","journal-title":"Journal of Evaluation in Clinical Practice"},{"issue":"15","key":"10206_CR33","doi-asserted-by":"crossref","first-page":"E347","DOI":"10.1093\/eurjpc\/zwac137","volume":"29","author":"E Fujii","year":"2022","unstructured":"Fujii, E., et al. (2022). Relationship between the prescription of sleep inducers and prognosis in patients with cardiovascular diseases. European Journal of Preventive Cardiology, 29(15), E347\u2013E349.","journal-title":"European Journal of Preventive Cardiology"},{"issue":"7","key":"10206_CR34","first-page":"E411","volume":"183","author":"KF Huybrechts","year":"2011","unstructured":"Huybrechts, K. F., et al. (2011). Risk ofdeath and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes CMAJ. Canadian Medical Association Journal, 183(7), E411\u2013E419.","journal-title":"Canadian Medical Association Journal"},{"issue":"2","key":"10206_CR35","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.atherosclerosis.2014.05.918","volume":"235","author":"CK Wu","year":"2014","unstructured":"Wu, C. K., et al. (2014). Anti-anxiety drugs use and cardiovascular outcomes in patients with myocardial infarction: A national wide assessment. Atherosclerosis, 235(2), 496\u2013502.","journal-title":"Atherosclerosis"},{"key":"10206_CR36","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013982","author":"Y Sato","year":"2020","unstructured":"Sato, Y., et al. (2020). Associations of benzodiazepine with adverse prognosis in heart failure patients with insomnia. Journal of the American Heart Association. https:\/\/doi.org\/10.1161\/JAHA.119.013982","journal-title":"Journal of the American Heart Association"},{"key":"10206_CR37","doi-asserted-by":"crossref","unstructured":"Saito, T. (2024). Suvorexant is associated with the reduced risk of feart failure rehospitalization in elderly patients with heart failure and insomnia. Circulation, 150.","DOI":"10.1161\/circ.150.suppl_1.4118332"},{"key":"10206_CR38","doi-asserted-by":"crossref","unstructured":"Imamura, T., Ushijima, R., Sobajima, M., Fukuda, N., Ueno, H., & Kinugawa, K. (2024). Prognostic impact of insomnia in patients receiving trans-catheter aortic valve replacement. Journal of Cardiology, 84(2), 113-118.","DOI":"10.1016\/j.jjcc.2024.03.009"},{"issue":"18","key":"10206_CR39","first-page":"e876","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich, P. A., et al. (2022). 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: Executive summary: A report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines. Circulation, 145(18), e876\u2013e894.","journal-title":"Circulation"},{"issue":"4","key":"10206_CR40","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jacc.2012.09.038","volume":"61","author":"M Gheorghiade","year":"2013","unstructured":"Gheorghiade, M., et al. (2013). Rehospitalization for heart failure: Problems and perspectives. Journal of the American College of Cardiology, 61(4), 391\u2013403.","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"10206_CR41","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ejhf.2773","volume":"25","author":"DM Gualandro","year":"2023","unstructured":"Gualandro, D. M., et al. (2023). Acute heart failure after non-cardiac surgery: Incidence, phenotypes, determinants and outcomes. European Journal of Heart Failure, 25(3), 347\u2013357.","journal-title":"European Journal of Heart Failure"},{"key":"10206_CR42","doi-asserted-by":"crossref","unstructured":"Scicchitano, P. (2025). Congestion and systemic inflammation in acute heart failure: correlations and prognostic role. Frontiers in Cardiovascular Medicine, Volume 12\u20132025.","DOI":"10.3389\/fcvm.2025.1695500"},{"key":"10206_CR43","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1235178","volume":"10","author":"M Garofalo","year":"2023","unstructured":"Garofalo, M., et al. (2023). Inflammation in acute heart failure. Frontiers in Cardiovascular Medicine, 10, Article 1235178.","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"7","key":"10206_CR44","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2459\/JCM.0000000000000974","volume":"21","author":"NR Pugliese","year":"2020","unstructured":"Pugliese, N. R., et al. (2020). Persistent congestion, renal dysfunction and inflammatory cytokines in acute heart failure: A prognosis study. Journal of Cardiovascular Medicine, 21(7), 494\u2013502.","journal-title":"Journal of Cardiovascular Medicine"},{"issue":"5","key":"10206_CR45","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3390\/biomedicines12050951","volume":"12","author":"D Mocan","year":"2024","unstructured":"Mocan, D., et al. (2024). The congestion pandemic in acute heart failure patients. Biomedicines, 12(5), 951.","journal-title":"Biomedicines"},{"issue":"8","key":"10206_CR46","first-page":"517","volume":"78","author":"JF Williams","year":"1991","unstructured":"Williams, J. F. (1991). Cytochrome P450 isoforms. Regulation during infection, inflammation and by cytokines. The Journal of the Florida Medical Association, 78(8), 517\u2013519.","journal-title":"The Journal of the Florida Medical Association"},{"issue":"6","key":"10206_CR47","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1080\/15402002.2024.2379340","volume":"22","author":"JA Esquivel-Mendoza","year":"2024","unstructured":"Esquivel-Mendoza, J. A., et al. (2024). Examining the longitudinal effects of insomnia on depression and medication adherence in people living with HIV. Behavioral Sleep Medicine, 22(6), 873\u2013882.","journal-title":"Behavioral Sleep Medicine"},{"issue":"1","key":"10206_CR48","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/JCP.0000000000000257","volume":"35","author":"WV Bobo","year":"2015","unstructured":"Bobo, W. V., et al. (2015). Complexity of illness and adjunctive benzodiazepine use in outpatients with bipolar I or II disorder: Results from the Bipolar CHOICE study. Journal Of Clinical Psychopharmacology, 35(1), 68\u201374.","journal-title":"Journal Of Clinical Psychopharmacology"},{"key":"10206_CR49","volume":"12","author":"Y Chen","year":"2024","unstructured":"Chen, Y., et al. (2024). The effects of psychiatric disorders on the risk of chronic heart failure: A univariable and multivariable Mendelian randomization study. Frontiers in Public Health, 12, Article 1306150.","journal-title":"Frontiers in Public Health"},{"issue":"11","key":"10206_CR50","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.101987","volume":"48","author":"S Rashid","year":"2023","unstructured":"Rashid, S., et al. (2023). Anxiety and depression in heart failure: An updated review. Current Problems in Cardiology, 48(11), Article 101987.","journal-title":"Current Problems in Cardiology"},{"issue":"10","key":"10206_CR51","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1016\/S2215-0366(23)00289-4","volume":"10","author":"S Kinoshita","year":"2023","unstructured":"Kinoshita, S., & Kishimoto, T. (2023). The use of a national identification system to prevent misuse of benzodiazepines and Z-drugs in Japan. The Lancet Psychiatry, 10(10), e26.","journal-title":"The Lancet Psychiatry"},{"issue":"7","key":"10206_CR52","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20075373","volume":"20","author":"Y Aoki","year":"2023","unstructured":"Aoki, Y., et al. (2023). A comparison between perceptions of psychiatric outpatients and psychiatrists regarding benzodiazepine use and decision making for its discontinuation: A cross-sectional survey in Japan. International Journal of Environmental Research and Public Health, 20(7), Article 5373.","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"10206_CR53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.drugalcdep.2018.02.011","volume":"187","author":"B Cook","year":"2018","unstructured":"Cook, B., et al. (2018). Examining racial\/ethnic differences in patterns of benzodiazepine prescription and misuse. Drug And Alcohol Dependence, 187, 29\u201334.","journal-title":"Drug And Alcohol Dependence"},{"key":"10206_CR54","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.12659\/MSM.905337","volume":"23","author":"Z Zhong","year":"2017","unstructured":"Zhong, Z., et al. (2017). Analysis of CYP2C19 genetic polymorphism in a large ethnic Hakka population in southern China. Medical Science Monitor, 23, 6186\u20136192.","journal-title":"Medical Science Monitor"},{"issue":"5","key":"10206_CR55","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2710.1999.00247.x","volume":"24","author":"E Tanaka","year":"1999","unstructured":"Tanaka, E. (1999). Clinically significant pharmacokinetic drug interactions with benzodiazepines. Journal of Clinical Pharmacy and Therapeutics, 24(5), 347\u2013355.","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"issue":"8","key":"10206_CR56","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1002\/ejhf.3352","volume":"26","author":"M Yang","year":"2024","unstructured":"Yang, M., et al. (2024). Geographical variation in patient characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction. European Journal Of Heart Failure, 26(8), 1788\u20131803.","journal-title":"European Journal Of Heart Failure"},{"issue":"2","key":"10206_CR57","first-page":"176","volume":"3","author":"WK Cornwell","year":"2015","unstructured":"Cornwell, W. K., & Levine, B. D. (2015). Patients with heart failure with reduced ejection fraction have exaggerated reductions in cerebral blood flow during upright posture\u2217. JACC: Heart Failure, 3(2), 176\u2013179.","journal-title":"JACC: Heart Failure"},{"issue":"1","key":"10206_CR58","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/bcp.13760","volume":"85","author":"AA Mangoni","year":"2019","unstructured":"Mangoni, A. A., & Jarmuzewska, E. A. (2019). The influence of heart failure on the pharmacokinetics of cardiovascular and non-cardiovascular drugs: A critical appraisal of the evidence. British Journal of Clinical Pharmacology, 85(1), 20\u201336.","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"12","key":"10206_CR59","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s40262-014-0189-3","volume":"53","author":"R Ogawa","year":"2014","unstructured":"Ogawa, R., Stachnik, J. M., & Echizen, H. (2014). Clinical pharmacokinetics of drugs in patients with heart failure: An update (Part 2, drugs administered orally). Clinical Pharmacokinetics, 53(12), 1083\u20131114.","journal-title":"Clinical Pharmacokinetics"},{"issue":"8","key":"10206_CR60","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.cardfail.2025.04.016","volume":"31","author":"JP Ferreira","year":"2025","unstructured":"Ferreira, J. P., & Zannad, F. (2025). Screening for undiagnosed heart failure: A viewpoint. Journal of Cardiac Failure, 31(8), 1339\u20131344.","journal-title":"Journal of Cardiac Failure"},{"issue":"9","key":"10206_CR61","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.cardfail.2021.05.014","volume":"27","author":"CW Wong","year":"2021","unstructured":"Wong, C. W., et al. (2021). Misdiagnosis of heart failure: A systematic review of the literature. Journal of Cardiac Failure, 27(9), 925\u2013933.","journal-title":"Journal of Cardiac Failure"},{"issue":"42","key":"10206_CR62","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1093\/eurheartj\/ehae544","volume":"45","author":"KM Talha","year":"2024","unstructured":"Talha, K. M., Metra, M., & Butler, J. (2024). Heart failure with preserved ejection fraction: Underdiagnosed and undertreated in patients with tricuspid regurgitation. European Heart Journal, 45(42), 4539\u20134541.","journal-title":"European Heart Journal"},{"key":"10206_CR63","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001402","author":"M Gurvitz","year":"2025","unstructured":"Gurvitz, M., Writing Committee Members\u2217, et al. (2025). 2025 ACC\/AHA\/HRS\/ISACHD\/SCAI guideline for the management of adults with congenital heart disease: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. https:\/\/doi.org\/10.1161\/CIR.0000000000001402","journal-title":"Circulation"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-026-10206-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-026-10206-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-026-10206-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:46:54Z","timestamp":1792144014000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-026-10206-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":63,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10206"],"URL":"https:\/\/doi.org\/10.1007\/s12012-026-10206-8","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"16 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"125"}}